Currently, there are 1.34B common shares owned by the public and among those 1.33B shares have been available to trade.
The company’s stock has a 5-day price change of 2.56% and 9.69% over the past three months. RTX shares are trading 21.83% year to date (YTD), with the 12-month market performance up to 30.01% higher. It has a 12-month low price of $99.07 and touched a high of $140.65 over the same period. RTX has an average intraday trading volume of 5.37 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 4.05%, 8.31%, and 13.06% respectively.
Institutional ownership of RTX Corp (NYSE: RTX) shares accounts for 82.48% of the company’s 1.34B shares outstanding.
It has a market capitalization of $188.34B and a beta (3y monthly) value of 0.62. The stock’s trailing 12-month PE ratio is 41.34, while the earnings-per-share (ttm) stands at $3.41. The company has a PEG of 4.38 and a Quick Ratio of 0.75 with the debt-to-equity ratio at 0.70. Price movements for the stock have been influenced by the stock’s volatility, which stands at 0.57% over the week and 1.18% over the month.
Analysts forecast that RTX Corp (RTX) will achieve an EPS of 1.43 for the current quarter, 1.46 for the next quarter and 6.68 for current fiscal year. The lowest estimate earnings-per-share for the quarter is 1.14 while analysts give the company a high EPS estimate of 1.14. Comparatively, EPS for the current quarter was 1.41 a year ago. Earnings per share for the fiscal year are expected to increase by 4.57%, and 12.05% over the next financial year. EPS should grow at an annualized rate of 9.44% over the next five years, compared to -11.13% over the past 5-year period.
Looking at the support for the RTX, a number of firms have released research notes about the stock. The Benchmark Company stated their Buy rating for the stock in a research note on May 14, 2025, with the firm’s price target at $140. DZ Bank coverage for the RTX Corp (RTX) stock in a research note released on April 25, 2025 offered a Hold rating with a price target of $129. Morgan Stanley was of a view on April 23, 2025 that the stock is Overweight, while Robert W. Baird gave the stock Outperform rating on March 19, 2025, issuing a price target of $136- $160. UBS on their part issued Buy rating on February 24, 2025.
